semaglutide heart disease: may reduce risk by up to 20% in 6 months Real-world data link semaglutide, tirzepatide

If pioglitazone is used in combination with insulin, especially in patients with risk factors for development of cardiac heart failure, patients should be observed for signs and symptoms of heart failure, weight gain and oedema

When Mounjaro launched in the UK in 2024, it was priced lower than in other European markets to support faster access

For injectable GLP-1 medications, diarrhoea generally does not significantly impact absorption since

O., Fujita, W

What the current research actually says Honesty matters more than enthusiasm when evaluating an untested combination

The same dose strengths are available: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg